Singapore markets close in 1 minute
Straits Times Index
3,294.93 +2.24 (+0.07%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,207.13 +444.10 (+2.50%) FTSE 100
8,151.80 +30.56 (+0.38%) Bitcoin USD
57,806.42 +775.75 (+1.36%) CMC Crypto 200
1,267.69 -3.05 (-0.24%)
SAB Biotherapeutics, Inc. (SABS)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 37.82M |
| Enterprise value | -12.83M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.66 |
| Enterprise value/revenue | -3.43 |
| Enterprise value/EBITDA | 0.34 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | -54.44% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 11.9000 |
| 52-week low 3 | 4.0000 |
| 50-day moving average 3 | 4.7063 |
| 200-day moving average 3 | 6.7186 |
Share statistics
| Avg vol (3-month) 3 | 13.29k |
| Avg vol (10-day) 3 | 1.65k |
| Shares outstanding 5 | 9.23M |
| Implied shares outstanding 6 | 9.23M |
| Float 8 | 5.93M |
| % held by insiders 1 | 19.13% |
| % held by institutions 1 | 38.41% |
| Shares short (15 Apr 2024) 4 | 25.62k |
| Short ratio (15 Apr 2024) 4 | 2.2 |
| Short % of float (15 Apr 2024) 4 | 0.37% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.28% |
| Shares short (prior month 15 Mar 2024) 4 | 20.89k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 05 Jan 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -6,187.90% |
Management effectiveness
| Return on assets (ttm) | -35.29% |
| Return on equity (ttm) | -95.51% |
Income statement
| Revenue (ttm) | 2.24M |
| Revenue per share (ttm) | 0.41 |
| Quarterly revenue growth (yoy) | -85.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -34.42M |
| Net income avi to common (ttm) | -42.19M |
| Diluted EPS (ttm) | -7.6400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 56.57M |
| Total cash per share (mrq) | 6.13 |
| Total debt (mrq) | 5.91M |
| Total debt/equity (mrq) | 10.31% |
| Current ratio (mrq) | 5.45 |
| Book value per share (mrq) | 6.21 |
Cash flow statement
| Operating cash flow (ttm) | -25.12M |
| Levered free cash flow (ttm) | -17.95M |
© 2024 Yahoo. All rights reserved.